Resources

Positive results are dependent upon BMI at start of therapy

A new once-weekly formulation of exenatide improves glycemic control and fosters weight loss in patients with type 2 diabetes, according to a new report.

Type 2 diabetes has a negative effect on brain tissue volumes and regional cerebral perfusion in elderly patients, according to researchers

Saliva may be a marker for both periodontal disease activity and hyperglycemia in uncontrolled type 2 diabetes, according to new research.

Researchers have discovered a potential new target for treating type 2 diabetes, according to a new study that appeared online in Nature. The target is a protein, along with its molecular partner, that regulates fat metabolism.

In a discovery that may explain the successes of the Atkins diet, investigators have found that a single hormone may switch on the use of stored fat for fuel when all else fails.

High glycosylated hemoglobin levels in women with gestational diabetes are associated with the development of diabetes in the future, new research indicates.

Doctors need to use these systems as part of overall improvement plan, but the electronic medical record systems are no guarantee that diabetes patients will get better care, a new study finds.

Exenatide can be an alternative to insulin glargine as an add-on treatment in patients with type 2 diabetes who are already receiving single-agent oral therapy, as presented as new research.

The U.S. FDA last week approved the 7-day use sensor to go with their CGMS system, a device that measures glucose levels continuously for up to seven days in people with diabetes.